Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators

Journal: Nature Nanotechnology

Published: 2019-08-05

DOI: 10.1038/s41565-019-0512-0

Affiliations: 6

Authors: 16

Go to article
Institutions Share
Research Institute for Medicines (iMed), ULisboa, Portugal 0.38
Department of Physiology and Pharmacology, TAU, Israel 0.31
Department of Pathology, TAU, Israel 0.13
Department of Immunology, WIS, Israel 0.09
Department of Chemistry and Biochemistry (DQB), ULISBOA, Portugal 0.06
Department of Drug Science and Technology (DSTF), UNITO, Italy 0.03